Contact Us
Drug Search Results
More Filters [+]

Temoporfin

Alternative Names: temoporfin, foscan
Latest Update: 2024-04-04
Latest Update Note: PubMed Publication

Product Description

Mechanisms of Action: Free Radical Inducer

Novel Mechanism: No

Modality: Small Molecule

Route of Administration: Intravenous

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: Austria | Belgium | Croatia | Czech | Estonia | European Medicines Agency | Finland | France | Germany | Greece | Hungary | Iceland | India | Ireland | Italy | Latvia | Lithuania | Netherlands | Poland | Portugal | Slovakia | Spain | Sweden | United Kingdom

Approved Indications: None

Known Adverse Events: None

Company: Quintiles IMS
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Temoporfin

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Phase 4: Cholangiocarcinoma

Phase 2: Nasopharyngeal Cancer|Squamous Cell Carcinoma|Ductal Carcinoma|Head and Neck Cancer|Oncology Unspecified|Cholangiocarcinoma|Klatskin Tumor

Phase 1: Non-Small-Cell Lung Cancer

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success
CARP

P4

Recruiting

Cholangiocarcinoma

2027-12-31

PDT

P2

Completed

Cholangiocarcinoma|Klatskin Tumor

2023-04-12

I 228112

P1

Completed

Non-Small-Cell Lung Cancer

2018-09-04

NCT01637376

P1

Withdrawn

Non-Small-Cell Lung Cancer

2014-01-01

Recent News Events

Date

Type

Title

04/04/2024

PubMed

 Photoactive imaging and therapy for colorectal cancer using a CEA-Affimer conjugated Foslip nanoparticle.

03/25/2024

PubMed

 Comparative response to PDT with methyl-aminolevulinate and temoporfin in cutaneous and oral squamous cell carcinoma cells.

02/28/2024

PubMed

 Enhancing photodynamic therapy efficacy through silica nanoparticle-mediated delivery of temoporfin for targeted in vitro breast cancer treatment.

12/23/2021

News Article

 Light Activated Therapies Global Market Forecasts 2021-2030, Featuring Advanz Pharma, Biofrontera, Biolitec Pharma, Luzitin and Theralase

03/18/2020

News Article

 Global Cancer Photodynamic Therapy Market & Clinical Trial Insight 2026 - ResearchAndMarkets.com

03/11/2020

News Article

 2020 Insights on the Global Cancer Photodynamic Therapy & Clinical Trial Market to 2026

03/09/2020

News Article

 Outlook into the Global Cancer Photodynamic Therapy Market (2020 to 2026) - US is Dominating Global Clinical Trials Landscape

Did PRYZM just deliver the data you were looking for?
Did you try our Excel download too?

Now that you’ve used PRYZM, we hope you’re able to see for yourself that it was designed and developed by people who actually use this data for a living. By applying next-generation technology for aggregating and curating this info across multiple key sources PRYZM delivering the latest information at your fingertips just the way you need it and with industry leading speed and cost effectiveness.

Our subscribers enjoy unlimited searches and receive this data on their own secure instance so they can overlay any additional internal/proprietary data on top of the search results and blend that data with real-time industry intel from PRYZM. Discover how you can continue to uncover the competitive landscape and drive strategy.

Suggestions